Biocon Biologics receives U.S. FDA approval for Jobevne
JOBEVNE, a recombinant humanized monoclonal antibody used to treat several different types of cancer, is a biosimilar to the reference product Avastin (bevacizumab).

What's Your Reaction?







Or register with email
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
Kartavya News Apr 2, 2025 0
Total Vote: 2
contact.kartavyanews@gmail.comTotal Vote: 2
YesTotal Vote: 3
Yes